IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH
On the accomplishment of the present study, I would like to take this opportunity to extend my deepest sense of gratitude and words of appreciation towards those, who helped me during the pursuit of study. I deem it a proud privilege and feel immense pleasure to acknowledge all those who are dire...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Tráchtas |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
DEPARTMENT OF SCIENCE AND HUMANITIES
2019
|
| Rochtain ar líne: | http://hdl.handle.net/123456789/396 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla: IDENTIFICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH
- IDENTICATION OF ANTICANCER DRUG THROUGH STUDYING THE ACTIVATION MECHANISM OF CASPASE PROTEIN: AN IN SILICO APPROACH /
- STRUCTURAL CHARACTERIZATION OF LEGIONELLOSIS DRUG TARGET CANDIDATE ENZYME PHOSPHOMANNOMUTASE FROM LEGIONELLA PNEUMOPHILA STRAIN PARIS: AN IN SILICO APPROACH
- AN IN-SILICO APPROACH TO COMPARE MUTANT E PROTEIN STRUCTURE BETWEEN OLD AND RECENT DENGUE VIRUS EPISODES /
- AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /
- AN INTEGRATED TRANSCRIPTOMIC APPROACH TO IMMUNE PROFILING, HUB GENE DETECTION, AND IDENTIFICATION OF REPURPOSABLE DRUGS IN PANCREATIC CANCER /
- Combining Bayesian and Meta-heuristic approaches for the Protein Inference Problem